Beijing, China

Kaixiang Zhou

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kaixiang Zhou in Antibacterial Compounds

Introduction

Kaixiang Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of antibacterial compounds, focusing on developing innovative solutions to combat multidrug-resistant strains. His work is particularly relevant in today's healthcare landscape, where antibiotic resistance poses a serious threat.

Latest Patents

Kaixiang Zhou holds a patent for a compound with broad-spectrum antibacterial activity and its antibacterial composition. This compound, identified as BAB159, demonstrates remarkable antibacterial activity against various pathogens. The formula of this compound allows for effective in vivo pharmacokinetics and significant therapeutic effects. Notably, the combination of BAB159 with polymyxin E shows enhanced synergistic antibacterial activity, making it a promising candidate for treating infections caused by multidrug-resistant strains.

Career Highlights

Kaixiang Zhou is affiliated with China Agricultural University, where he conducts research and development in the field of antibacterial agents. His work has garnered attention for its potential applications in medicine and public health. With a focus on innovative solutions, Zhou continues to push the boundaries of what is possible in antibacterial research.

Collaborations

Kaixiang Zhou collaborates with esteemed colleagues such as Jianzhong Shen and Kui Zhu. Their combined expertise contributes to the advancement of research in antibacterial compounds and enhances the impact of their findings.

Conclusion

Kaixiang Zhou's innovative work in developing antibacterial compounds is crucial in addressing the challenges posed by antibiotic resistance. His contributions not only advance scientific knowledge but also hold the potential for significant improvements in healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…